Financial Snapshot

Revenue
$177.6M
TTM
Gross Margin
94.74%
TTM
Net Earnings
-$145.9M
TTM
Current Assets
Q2 2024
Current Liabilities
Q2 2024
Current Ratio
304.27%
Q2 2024
Total Assets
Q2 2024
Total Liabilities
Q2 2024
Book Value
$15.15M
Q2 2024
Cash
Q2 2024
P/E
-9.567
Oct 17, 2024 EST
Free Cash Flow
-$376.3M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Revenue $145.2M $212.0M $227.5M $198.3M $175.3M $164.2M $154.9M $133.6M $99.89M $28.20M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -31.5% -6.8% 14.71% 13.11% 6.75% 6.01% 15.98% 33.74% 254.19%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Revenue $145.2M $212.0M $227.5M $198.3M $175.3M $164.2M $154.9M $133.6M $99.89M $28.20M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost Of Revenue $11.45M $7.592M $6.784M $6.126M $5.234M $5.527M $3.605M $4.554M $2.185M $571.0K $0.00 $0.00
Gross Profit $133.8M $204.4M $220.7M $192.2M $170.1M $158.7M $151.3M $129.0M $97.71M $27.63M $0.00 $0.00
Gross Profit Margin 92.12% 96.42% 97.02% 96.91% 97.01% 96.63% 97.67% 96.59% 97.81% 97.98%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Selling, General & Admin $227.9M $220.2M $149.9M $135.8M $129.0M $103.7M $101.3M $91.94M $79.54M $59.65M $17.69M $29.60M $0.00 $0.00 $0.00 $0.00
YoY Change 3.48% 46.92% 10.37% 5.31% 24.41% 2.29% 10.22% 15.59% 33.36% 237.19% -40.24%
% of Gross Profit 170.32% 107.72% 67.91% 70.66% 75.81% 65.31% 66.96% 71.25% 81.41% 215.85%
Research & Development $237.7M $7.500M $210.3M $131.8M $141.0M $123.8M $78.17M $70.82M $50.43M $47.80M $7.084M $700.0K
YoY Change 3069.72% -96.43% 59.61% -6.52% 13.9% 58.32% 10.37% 40.45% 5.5% 574.69% 912.0%
% of Gross Profit 177.69% 3.67% 95.3% 68.56% 82.87% 77.97% 51.65% 54.89% 51.61% 172.97%
Depreciation & Amortization $44.93M $33.08M $26.62M $24.58M $20.41M $18.67M $17.80M $16.14M $13.39M $5.401M $216.0K $120.0K
YoY Change 35.83% 24.28% 8.29% 20.44% 9.32% 4.85% 10.34% 20.48% 147.95% 2400.46% 80.0%
% of Gross Profit 33.58% 16.18% 12.06% 12.79% 12.0% 11.76% 11.76% 12.5% 13.71% 19.55%
Operating Expenses $510.5M $227.7M $360.2M $267.6M $269.9M $244.3M $208.7M $191.8M $150.6M $108.0M $24.77M $30.30M $0.00 $0.00 $0.00 $0.00
YoY Change 124.21% -36.79% 34.62% -0.87% 10.49% 17.04% 8.82% 27.33% 39.47% 336.0% -18.24%
Operating Profit -$376.7M -$266.6M -$161.8M -$176.2M -$137.4M -$80.04M -$53.79M -$58.21M -$50.75M -$79.81M -$24.77M -$30.30M
YoY Change 41.33% 64.79% -8.17% 28.25% 71.62% 48.8% -7.6% 14.71% -36.41% 222.16% -18.24%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Interest Expense $10.43M $11.30M $20.10M $19.10M $18.80M $9.800M $4.400M $4.700M $7.700M $7.400M $0.00 -$100.0K $0.00 $0.00 $0.00 $0.00
YoY Change -7.66% -43.78% 5.24% 1.6% 91.84% 122.73% -6.38% -38.96% 4.05% -100.0%
% of Operating Profit
Other Income/Expense, Net $1.594M -$11.60M -$17.92M -$12.63M -$9.087M -$21.83M -$4.572M $632.0K $156.2M -$33.59M -$9.776M
YoY Change -113.74% -35.24% 41.89% 38.96% -58.37% 377.41% -823.42% -99.6% -565.06% 243.6%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Pretax Income -$376.1M -$278.2M -$179.7M -$188.8M -$146.4M -$101.9M -$58.36M -$57.58M $105.5M -$113.4M -$34.55M -$30.30M $0.00 $0.00 $0.00 $0.00
YoY Change 35.21% 54.81% -4.82% 28.91% 43.76% 74.54% 1.36% -154.6% -193.01% 228.22% 14.02%
Income Tax $223.0K $313.0K $409.0K -$19.36M -$21.00K $811.0K $1.368M -$9.679M -$11.77M -$2.460M $76.00K $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income -11.16%
Net Earnings -$111.4M -$278.5M -$180.1M -$169.4M -$146.4M -$102.7M -$59.73M -$47.90M $117.2M -$110.9M -$34.63M -$30.30M $0.00 $0.00 $0.00 $0.00
YoY Change -60.0% 54.63% 6.29% 15.71% 42.61% 71.9% 24.69% -140.86% -205.68% 220.4% 14.27%
Net Earnings / Revenue -76.7% -131.35% -79.16% -85.43% -83.51% -62.51% -38.55% -35.86% 117.36% -393.36%
Basic Earnings Per Share -$1.50 -$4.37 -$3.01 -$3.56 -$3.46 -$2.54 -$1.54 -$1.29 $3.49 -$4.43 -$2.44
Diluted Earnings Per Share -$1.49 -$4.37 -$3.01 -$3.56 -$3.46 -$2.54 -$1.54 -$1.29 $3.17 -$4.43 -$2.44 -$8.189M $0.00 $0.00 $0.00 $0.00

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
Cash & Short-Term Investments $566.9M $450.2M $552.9M $361.6M $398.5M $471.5M $300.6M $255.9M $229.6M $27.80M $6.100M $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 25.9% -18.56% 52.9% -9.26% -15.48% 56.85% 17.47% 11.45% 725.9% 355.74%
Cash & Equivalents $58.18M $61.69M $165.8M $84.80M $62.40M $102.9M $99.40M $41.00M $37.80M $18.20M $6.000M $0.00 $0.00 $0.00 $0.00 $0.00
Short-Term Investments $508.7M $388.6M $387.1M $276.8M $336.1M $368.7M $201.2M $214.9M $191.8M $9.600M $100.0K
Other Short-Term Assets $19.34M $12.62M $6.471M $8.100M $6.400M $5.900M $6.000M $8.300M $10.50M $800.0K $1.400M $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 53.16% 95.09% -20.11% 26.56% 8.47% -1.67% -27.71% -20.95% 1212.5% -42.86%
Inventory $9.410M $6.922M $7.313M $7.600M $6.100M $5.600M $5.400M $2.800M $2.500M $800.0K $0.00
Prepaid Expenses
Receivables $21.18M $16.65M $15.91M $15.90M $18.00M $12.70M $13.90M $18.50M $12.50M $8.000M $0.00
Other Receivables $0.00 $0.00 $247.0K $17.20M $0.00 $0.00 $0.00 $46.90M $46.80M $0.00 $0.00
Total Short-Term Assets $616.8M $486.4M $582.8M $410.4M $429.1M $495.7M $325.8M $332.4M $301.9M $37.30M $7.500M $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 26.79% -16.54% 42.01% -4.36% -13.44% 52.15% -1.99% 10.1% 709.38% 397.33%
Property, Plant & Equipment $25.54M $30.05M $34.30M $35.10M $9.900M $3.100M $3.200M $2.600M $400.0K $700.0K $100.0K $0.00
YoY Change -15.01% -12.4% -2.27% 254.55% 219.35% -3.13% 23.08% 550.0% -42.86% 600.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $15.00M
YoY Change -100.0%
Other Assets $42.16M $11.06M $11.07M $7.800M $7.700M $7.700M $5.600M $7.400M $1.900M $2.300M $300.0K
YoY Change 281.11% -0.07% 41.91% 1.3% 0.0% 37.5% -24.32% 289.47% -17.39% 666.67%
Total Long-Term Assets $172.1M $186.1M $193.8M $197.0M $175.7M $213.5M $194.5M $192.9M $210.4M $98.20M $13.00M $2.400M $0.00 $0.00 $0.00 $0.00
YoY Change -7.53% -3.95% -1.62% 12.12% -17.7% 9.77% 0.83% -8.32% 114.26% 655.38% 441.67%
Total Assets $788.9M $672.6M $776.6M $607.4M $604.8M $709.2M $520.3M $525.3M $512.3M $135.5M $20.50M $2.400M $0.00 $0.00 $0.00 $0.00
YoY Change
Accounts Payable $41.68M $17.29M $15.14M $12.10M $26.60M $7.000M $18.90M $7.500M $7.600M $7.100M $3.600M $1.000M $0.00 $0.00 $0.00 $0.00
YoY Change 141.04% 14.17% 25.16% -54.51% 280.0% -62.96% 152.0% -1.32% 7.04% 97.22% 260.0%
Accrued Expenses $123.9M $74.11M $52.25M $47.00M $38.30M $33.20M $24.00M $23.50M $18.60M $27.90M $4.900M $2.500M $0.00 $0.00 $0.00 $0.00
YoY Change 67.2% 41.84% 11.16% 22.72% 15.36% 38.33% 2.13% 26.34% -33.33% 469.39% 96.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $40.50M $0.00 $900.0K $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $0.00 $22.50M $1.000M $1.600M $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% -37.5%
Total Short-Term Liabilities $177.9M $142.2M $124.1M $92.70M $95.40M $104.6M $85.70M $83.30M $87.00M $107.5M $36.60M $5.800M $100.0K $100.0K $100.0K $0.00
YoY Change 25.14% 14.57% 33.86% -2.83% -8.8% 22.05% 2.88% -4.25% -19.07% 193.72% 531.03% 5700.0% 0.0% 0.0%
Long-Term Debt $377.3M $375.5M $226.6M $215.3M $204.9M $195.1M $45.10M $44.40M $43.80M $43.30M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 0.46% 65.74% 5.24% 5.08% 5.02% 332.59% 1.58% 1.37% 1.15%
Other Long-Term Liabilities $32.93M $112.0M $123.9M $88.20M $83.30M $91.20M $96.50M $83.40M $57.20M $21.80M $1.000M
YoY Change -70.6% -9.55% 40.42% 5.88% -8.66% -5.49% 15.71% 45.8% 162.39% 2080.0%
Total Long-Term Liabilities $410.2M $487.6M $350.4M $303.5M $288.2M $286.3M $141.6M $127.8M $101.0M $65.10M $1.000M $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -15.87% 39.13% 15.46% 5.31% 0.66% 102.19% 10.8% 26.53% 55.15% 6410.0%
Total Liabilities $588.1M $629.7M $474.5M $396.2M $383.6M $390.9M $227.2M $217.5M $212.3M $172.7M $40.20M $5.800M $100.0K $100.0K $100.0K $0.00
YoY Change -6.61% 32.71% 19.77% 3.28% -1.87% 72.05% 4.46% 2.45% 22.93% 329.6% 593.1% 5700.0% 0.0% 0.0%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $1.396 Billion

About Travere Therapeutics Inc

Travere Therapeutics, Inc. is a biopharmaceutical company. The company is headquartered in San Diego, California and currently employs 380 full-time employees. The company went IPO on 2003-07-23. The firm is focused on identifying, developing, and delivering life-changing therapies to people living with rare kidney and metabolic diseases. Its product, FILSPARI (sparsentan), is indicated to reduce proteinuria in adults with primary IgAN at risk of rapid disease progression. Sparsentan is also in late-stage development for focal segmental glomerulosclerosis (FSGS). The Company’s Pegtibatinase is a novel investigational human enzyme replacement candidate being evaluated for the treatment of classical homocystinuria (HCU), which is a rare metabolic disorder. Its commercial products, Thiola and Thiola EC are for the treatment of cystinuria, a rare genetic cystine transport disorder that causes high cystine levels in the urine and the formation of recurring kidney stones. The company is also engaged in the identification of potential small molecule therapeutics for Alagille syndrome (ALGS).

Industry: Pharmaceutical Preparations Peers: Agios Pharmaceuticals Inc Allogene Therapeutics Inc Iovance Biotherapeutics Inc Ironwood Pharmaceuticals Inc Lyell Immunopharma Inc Myriad Genetics Inc Novavax Inc Revolution Medicines Inc Recursion Pharmaceuticals Inc